Arcutis Biotherapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Arcutis Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Arcutis Biotherapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Arcutis Biotherapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $4.6M | 244k | 18.85 |
| 2025-06-30 | $5.7M | 405k | 14.02 |
| 2025-03-31 | $4.4M | 279k | 15.64 |
| 2024-12-31 | $3.9M | 280k | 13.93 |
| 2024-09-30 | $2.6M | 277k | 9.30 |
| 2024-06-30 | $2.5M | 274k | 9.30 |
| 2023-09-30 | $431k | 81k | 5.31 |
| 2023-06-30 | $656k | 60k | 11.00 |
| 2023-03-31 | $656k | 60k | 11.00 |
| 2022-12-31 | $499k | 34k | 14.80 |
| 2022-09-30 | $365k | 19k | 19.11 |
| 2022-06-30 | $639k | 30k | 21.31 |
| 2022-03-31 | $577k | 30k | 19.26 |
| 2021-12-31 | $622k | 30k | 20.74 |
| 2021-09-30 | $716k | 30k | 23.89 |
| 2021-06-30 | $818k | 30k | 27.29 |
| 2021-03-31 | $613k | 21k | 28.93 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas